Author Title Type [ Year(Asc)]
Filters: Author is Hashemi, Seyed Mahmoud  [Clear All Filters]
Taghavi-Farahabadi M, Mahmoudi M, Hashemi SMahmoud, Rezaei N. Evaluation of the effects of mesenchymal stem cells on neutrophils isolated from severe congenital neutropenia patients. Int Immunopharmacol. 2020;83:106463.
Salimi M, Shirazi A, Norouzian M, Mehrazar MMehdi, Naderi MMehdi, Shokrgozar MAli, Omrani M, Hashemi SMahmoud. Histone Modifications of H3K4me3, H3K9me3 and Lineage Gene Expressions in Chimeric Mouse Embryo. Cell J. 2020;22(1):96-105.
Taghavi-Farahabadi M, Mahmoudi M, Soudi S, Hashemi SMahmoud. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Med Hypotheses. 2020;144:109865.
Mokhberian N, Bolandi Z, Eftekhary M, Hashemi SMahmoud, Jajarmi V, Sharifi K, Ghanbarian H. Inhibition of miR-34a reduces cellular senescence in human adipose tissue-derived mesenchymal stem cells through the activation of SIRT1. Life Sci. 2020:118055.
Fathollahi A, Hashemi SMahmoud, Hoseini MHaji Molla, Tavakoli S, Farahani E, Yeganeh F. Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis. Int Immunopharmacol. 2020;90:107207.
Sadeghi S, Soudi S, Shafiee A, Hashemi SMahmoud. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action. Life Sci. 2020:118493.
Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad REslami, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SMahmoud, Łos MJ, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol. 2020:173263.